Sublingual Aspirin (Aspire Biopharma)

N/A

Report date: 2026/02/03 17:46:22

Base Information

Drug NameSublingual Aspirin (Aspire Biopharma)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclooxygenases inhibitors
TargetsCyclooxygenases
Therapy Area/IndicationsMyocardial Infarction
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAspire Biopharma Holdings Inc
China Registration ClassN/A

Develop Information

Active CompaniesAspire Biopharma Holdings IncMicrosize Inc
Inactive CompaniesN/A
Active IndicationsMyocardial Infarction
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A